| Year |
Citation |
Score |
| 2023 |
Lee J, Nicosia M, Hong ES, Silver DJ, Li C, Bayik D, Watson DC, Lauko A, Kay KE, Wang SZ, Johnson S, McGraw M, Grabowski MM, Kish DD, Desai AB, ... ... Lathia JD, et al. Sex-biased T cell exhaustion drives differential immune responses in glioblastoma. Cancer Discovery. PMID 37378557 DOI: 10.1158/2159-8290.CD-22-0869 |
0.451 |
|
| 2023 |
Alban TJ, Grabowski MM, Otvos B, Bayik D, Wang W, Zalavadia AH, Makarav V, Troike KM, McGraw M, Rabljenovic A, Lauko A, Neumann CK, Roversi G, Waite KA, Cioffi G, ... ... Lathia JD, et al. The SNP rs755622 is associated with immune activation in glioblastoma. Jci Insight. PMID 37252795 DOI: 10.1172/jci.insight.160024 |
0.521 |
|
| 2023 |
Grabowski MM, Watson DC, Chung K, Lee J, Bayik D, Lauko A, Alban T, Melenhorst JJ, Chan T, Lathia JD, Ahluwalia MS, Mohammadi AM. Spatial immunosampling of MRI-defined glioblastoma regions reveals immunologic fingerprint of non-contrast enhancing, infiltrative tumor margins. Medrxiv : the Preprint Server For Health Sciences. PMID 36945620 DOI: 10.1101/2023.03.09.23285970 |
0.55 |
|
| 2023 |
Dhawan A, Manem VSK, Yeaney G, Lathia JD, Ahluwalia MS. EGFR Pathway Expression Persists in Recurrent Glioblastoma Independent of Amplification Status. Cancers. 15. PMID 36765632 DOI: 10.3390/cancers15030670 |
0.488 |
|
| 2023 |
Mitchell K, Sprowls SA, Arora S, Shakya S, Silver DJ, Goins CM, Wallace L, Roversi G, Schafer R, Kay K, Miller TE, Lauko A, Bassett J, Kashyap A, D'Amato Kass J, ... ... Lathia JD, et al. WDR5 represents a therapeutically exploitable target for cancer stem cells in glioblastoma. Genes & Development. PMID 36732025 DOI: 10.1101/gad.349803.122 |
0.317 |
|
| 2022 |
Chambers LM, Esakov Rhoades EL, Bharti R, Braley C, Tewari S, Trestan L, Alali Z, Bayik D, Lathia JD, Sangwan N, Bazeley P, Joehlin-Price AS, Wang Z, Dutta S, Dwidar M, et al. Disruption of the gut microbiota confers cisplatin resistance in epithelial ovarian cancer. Cancer Research. PMID 36206317 DOI: 10.1158/0008-5472.CAN-22-0455 |
0.336 |
|
| 2022 |
Bayik D, Bartels CF, Lovrenert K, Watson DC, Zhang D, Kay K, Lee J, Lauko A, Johnson S, Lo A, Silver DJ, McGraw M, Grabowski MM, Mohammadi AM, Veglia F, ... ... Lathia JD, et al. Distinct cell adhesion signature defines glioblastoma myeloid-derived suppressor cell subsets. Cancer Research. PMID 36126163 DOI: 10.1158/0008-5472.CAN-21-3840 |
0.425 |
|
| 2022 |
Lauko A, Volovetz J, Turaga SM, Bayik D, Silver DJ, Mitchell K, Mulkearns-Hubert EE, Watson DC, Desai K, Midha M, Hao J, McCortney K, Steffens A, Naik U, Ahluwalia MS, ... ... Lathia JD, et al. SerpinB3 drives cancer stem cell survival in glioblastoma. Cell Reports. 40: 111348. PMID 36103817 DOI: 10.1016/j.celrep.2022.111348 |
0.568 |
|
| 2022 |
Tewari S, Tom MC, Park DYJ, Wei W, Chao ST, Yu JS, Suh JH, Kilic S, Peereboom DM, Stevens GHJ, Lathia JD, Prayson R, Barnett GH, Angelov L, Mohammadi AM, et al. Sex-Specific Differences in Low Grade Glioma Presentation and Outcome. International Journal of Radiation Oncology, Biology, Physics. PMID 35667529 DOI: 10.1016/j.ijrobp.2022.05.036 |
0.461 |
|
| 2021 |
Knudsen AM, Halle B, Cédile O, Burton M, Baun C, Thisgaard H, Anand A, Hubert C, Thomassen M, Michaelsen SR, Olsen BB, Dahlrot RH, Bjerkvig R, Lathia JD, Kristensen BW. Surgical resection of glioblastomas induces pleiotrophin-mediated self-renewal of glioblastoma stem cells in recurrent tumors. Neuro-Oncology. PMID 34964899 DOI: 10.1093/neuonc/noab302 |
0.346 |
|
| 2021 |
Cable J, Pei D, Reid LM, Wang XW, Bhatia S, Karras P, Melenhorst JJ, Grompe M, Lathia JD, Song E, Kuo CJ, Zhang N, White RM, Ma SK, Ma L, et al. Cancer stem cells: advances in biology and clinical translation-a Keystone Symposia report. Annals of the New York Academy of Sciences. PMID 34850398 DOI: 10.1111/nyas.14719 |
0.374 |
|
| 2021 |
Kotian N, Troike KM, Curran KN, Lathia JD, McDonald JA. A Drosophila RNAi screen reveals conserved glioblastoma-related adhesion genes that regulate collective cell migration. G3 (Bethesda, Md.). PMID 34849760 DOI: 10.1093/g3journal/jkab356 |
0.353 |
|
| 2021 |
Lee J, Kay K, Troike K, Ahluwalia MS, Lathia JD. Sex Differences in Glioblastoma Immunotherapy Response. Neuromolecular Medicine. PMID 33864598 DOI: 10.1007/s12017-021-08659-x |
0.549 |
|
| 2021 |
Lauko A, Lo A, Ahluwalia MS, Lathia JD. Cancer cell heterogeneity & plasticity in glioblastoma and brain tumors. Seminars in Cancer Biology. PMID 33640445 DOI: 10.1016/j.semcancer.2021.02.014 |
0.592 |
|
| 2021 |
Otvos B, Alban TJ, Grabowski MM, Bayik D, Mulkearns-Hubert EE, Radivoyevitch T, Rabljenovic A, Johnson S, Androjna C, Mohammadi AM, Barnett GH, Ahluwalia MS, Vogelbaum MA, Fecci PE, Lathia JD. Preclinical modeling of surgery and steroid therapy for glioblastoma reveals changes in immunophenotype that are associated with tumor growth and outcome. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 33542075 DOI: 10.1158/1078-0432.CCR-20-3262 |
0.562 |
|
| 2021 |
Alban TJ, Bayik D, Alvarado AG, Kornblum HI, Lathia JD. High-Dimensional Analysis of Circulating and Tissue-Derived Myeloid-Derived Suppressor Cells from Patients with Glioblastoma. Methods in Molecular Biology (Clifton, N.J.). 2236: 157-175. PMID 33237547 DOI: 10.1007/978-1-0716-1060-2_13 |
0.301 |
|
| 2020 |
Bayik D, Lauko AJ, Roversi GA, Serbinowski E, Acevedo-Moreno LA, Lanigan C, Orujov M, Lo A, Alban TJ, Kim A, Silver DJ, Nagy LE, Brown JM, Allende DS, Aucejo FN, ... Lathia JD, et al. Hepatobiliary malignancies have distinct peripheral myeloid-derived suppressor cell signatures and tumor myeloid cell profiles. Scientific Reports. 10: 18848. PMID 33139767 DOI: 10.1038/s41598-020-75881-1 |
0.307 |
|
| 2020 |
Tao W, Zhang A, Zhai K, Huang Z, Huang H, Zhou W, Huang Q, Fang X, Prager BC, Wang X, Wu Q, Sloan AE, Ahluwalia MS, Lathia JD, Yu JS, et al. SATB2 drives glioblastoma growth by recruiting CBP to promote FOXM1 expression in glioma stem cells. Embo Molecular Medicine. e12291. PMID 33124191 DOI: 10.15252/emmm.202012291 |
0.525 |
|
| 2020 |
Lauko A, Mu Z, Gutmann DH, Naik UP, Lathia JD. Junctional adhesion molecules in cancer: a paradigm for the diverse functions of cell-cell interactions in tumor progression. Cancer Research. PMID 32816855 DOI: 10.1158/0008-5472.Can-20-1829 |
0.308 |
|
| 2020 |
Alban TJ, Bayik D, Otvos B, Rabljenovic A, Leng L, Jia-Shiun L, Roversi G, Lauko A, Momin AA, Mohammadi AM, Peereboom DM, Ahluwalia MS, Matsuda K, Yun K, Bucala R, ... ... Lathia JD, et al. Glioblastoma Myeloid-Derived Suppressor Cell Subsets Express Differential Macrophage Migration Inhibitory Factor Receptor Profiles That Can Be Targeted to Reduce Immune Suppression. Frontiers in Immunology. 11: 1191. PMID 32625208 DOI: 10.3389/Fimmu.2020.01191 |
0.593 |
|
| 2020 |
Turaga SM, Silver DJ, Bayik D, Paouri E, Peng S, Lauko A, Alban TJ, Borjini N, Stanko S, Naik U, Keri RA, Connor JR, Barnholtz-Sloan JS, Rubin JB, Berens M, ... ... Lathia JD, et al. JAM-A functions as a female microglial tumor suppressor in glioblastoma. Neuro-Oncology. PMID 32592484 DOI: 10.1093/Neuonc/Noaa148 |
0.435 |
|
| 2020 |
Bayik D, Zhou Y, Park C, Hong C, Vail D, Silver DJ, Lauko A, Roversi G, Watson DC, Lo A, Alban TJ, McGraw M, Sorensen M, Grabowski MM, Otvos B, ... ... Lathia JD, et al. Myeloid-derived suppressor cell subsets drive glioblastoma growth in a sex-specific manner. Cancer Discovery. PMID 32300059 DOI: 10.1158/2159-8290.Cd-19-1355 |
0.578 |
|
| 2020 |
Volovetz J, Berezovsky AD, Alban T, Chen Y, Lauko A, Aranjuez GF, Burtscher A, Shibuya K, Silver DJ, Peterson J, Manor D, McDonald JA, Lathia JD. Identifying conserved molecular targets required for cell migration of glioblastoma cancer stem cells. Cell Death & Disease. 11: 152. PMID 32102991 DOI: 10.1038/S41419-020-2342-2 |
0.374 |
|
| 2020 |
Lathia J, Liu H, Matei D. The Clinical Impact of Cancer Stem Cells. The Oncologist. 25: 123-131. PMID 32043793 DOI: 10.1634/Theoncologist.2019-0517 |
0.338 |
|
| 2019 |
Peereboom DM, Alban TJ, Grabowski MM, Alvarado AG, Otvos B, Bayik D, Roversi G, McGraw M, Huang P, Mohammadi AM, Kornblum HI, Radivoyevitch T, Ahluwalia MS, Vogelbaum MA, Lathia JD. Metronomic capecitabine as an immune modulator in glioblastoma patients reduces myeloid-derived suppressor cells. Jci Insight. PMID 31600167 DOI: 10.1172/jci.insight.130748 |
0.583 |
|
| 2019 |
Jimenez-Pascual A, Hale JS, Kordowski A, Pugh J, Silver DJ, Bayik D, Roversi G, Alban TJ, Rao S, Chen R, McIntyre TM, Colombo G, Taraboletti G, Holmberg KO, Forsberg-Nilsson K, ... Lathia JD, et al. ADAMDEC1 maintains a growth factor signaling loop in cancer stem cells. Cancer Discovery. PMID 31434712 DOI: 10.1158/2159-8290.Cd-18-1308 |
0.319 |
|
| 2019 |
Mulkearns-Hubert EE, Torre-Healy LA, Silver DJ, Eurich JT, Bayik D, Serbinowski E, Hitomi M, Zhou J, Przychodzen B, Zhang R, Sprowls SA, Hale JS, Alban TJ, Berezovsky A, Bell BA, ... ... Lathia JD, et al. Development of a Cx46 Targeting Strategy for Cancer Stem Cells. Cell Reports. 27: 1062-1072.e5. PMID 31018124 DOI: 10.1016/j.celrep.2019.03.079 |
0.372 |
|
| 2019 |
Saygin C, Matei D, Majeti R, Reizes O, Lathia JD. Targeting Cancer Stemness in the Clinic: From Hype to Hope. Cell Stem Cell. 24: 25-40. PMID 30595497 DOI: 10.1016/J.Stem.2018.11.017 |
0.342 |
|
| 2018 |
Alban TJ, Alvarado AG, Sorensen MD, Bayik D, Volovetz J, Serbinowski E, Mulkearns-Hubert EE, Sinyuk M, Hale JS, Onzi GR, McGraw M, Huang P, Grabowski MM, Wathen CA, Ahluwalia MS, ... ... Lathia JD, et al. Global immune fingerprinting in glioblastoma patient peripheral blood reveals immune-suppression signatures associated with prognosis. Jci Insight. 3. PMID 30385717 DOI: 10.1172/jci.insight.122264 |
0.565 |
|
| 2018 |
Jarrar A, Lotti F, DeVecchio J, Ferrandon S, Gantt G, Mace A, Karagkounis G, Orloff M, Venere M, Hitomi M, Lathia J, Rich JN, Kalady MF. PARP inhibition sensitizes colorectal cancer-initiating cells to chemotherapy. Stem Cells (Dayton, Ohio). PMID 30353615 DOI: 10.1002/Stem.2929 |
0.328 |
|
| 2018 |
Silver DJ, Lathia JD. Therapeutic Injury and Tumor Regrowth: Tumor Resection and Radiation Establish the Recurrent Glioblastoma Microenvironment. Ebiomedicine. 31: 13-14. PMID 29699876 DOI: 10.1016/j.ebiom.2018.04.016 |
0.309 |
|
| 2017 |
Ma Y, Cheng Z, Liu J, Torre-Healy L, Lathia JD, Nakano I, Guo Y, Thompson RC, Freeman ML, Wang J. Inhibition of Farnesyltransferase Potentiates NOTCH-Targeted Therapy against Glioblastoma Stem Cells. Stem Cell Reports. 9: 1948-1960. PMID 29198824 DOI: 10.1016/j.stemcr.2017.10.028 |
0.362 |
|
| 2017 |
Müller-Greven GM, Carlin C, Burgett ME, Ahluwalia MS, Lauko A, Nowacki AS, Herting CJ, Qadan MA, Bredel M, Toms SA, Lathia JD, Hambardzumyan D, Sarkaria JN, Hamerlik P, Gladson CL. Macropinocytosis of Bevacizumab by Glioblastoma Cells in the Perivascular Niche Affects their Survival. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 28912141 DOI: 10.1158/1078-0432.Ccr-17-0249 |
0.559 |
|
| 2017 |
Rosager AM, Sørensen MD, Dahlrot RH, Hansen S, Schonberg DL, Rich JN, Lathia JD, Kristensen BW. Transferrin receptor-1 and ferritin heavy and light chains in astrocytic brain tumors: Expression and prognostic value. Plos One. 12: e0182954. PMID 28837569 DOI: 10.1371/journal.pone.0182954 |
0.378 |
|
| 2017 |
Karunanithi S, Levi L, DeVecchio J, Karagkounis G, Reizes O, Lathia JD, Kalady MF, Noy N. RBP4-STRA6 Pathway Drives Cancer Stem Cell Maintenance and Mediates High-Fat Diet-Induced Colon Carcinogenesis. Stem Cell Reports. PMID 28689994 DOI: 10.1016/J.Stemcr.2017.06.002 |
0.318 |
|
| 2017 |
Abou-Antoun TJ, Hale JS, Lathia JD, Dombrowski SM. Brain Cancer Stem Cells in Adults and Children: Cell Biology and Therapeutic Implications. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. PMID 28374184 DOI: 10.1007/S13311-017-0524-0 |
0.377 |
|
| 2016 |
Alvarado AG, Thiagarajan PS, Mulkearns-Hubert EE, Silver DJ, Hale JS, Alban TJ, Turaga SM, Jarrar A, Reizes O, Longworth MS, Vogelbaum MA, Lathia JD. Glioblastoma Cancer Stem Cells Evade Innate Immune Suppression of Self-Renewal through Reduced TLR4 Expression. Cell Stem Cell. PMID 28089910 DOI: 10.1016/j.stem.2016.12.001 |
0.311 |
|
| 2016 |
Munthe S, Sørensen MD, Thomassen M, Burton M, Kruse TA, Lathia JD, Poulsen FR, Kristensen BW. Migrating glioma cells express stem cell markers and give rise to new tumors upon xenografting. Journal of Neuro-Oncology. PMID 27510953 DOI: 10.1007/s11060-016-2221-y |
0.425 |
|
| 2016 |
Burgett ME, Lathia JD, Roth P, Nowacki AS, Galileo DS, Pugacheva E, Huang P, Vasanji A, Li M, Byzova T, Mikkelsen T, Bao S, Rich JN, Weller M, Gladson CL. Direct contact with perivascular tumor cells enhances integrin αvβ3 signaling and migration of endothelial cells. Oncotarget. PMID 27270311 DOI: 10.18632/Oncotarget.9700 |
0.375 |
|
| 2016 |
Otvos B, Silver DJ, Mulkearns-Hubert EE, Alvarado AG, Turaga SM, Sorensen MD, Rayman P, Flavahan WA, Hale JS, Stoltz K, Sinyuk M, Wu Q, Jarrar A, Kim SH, Fox PL, ... ... Lathia JD, et al. Cancer stem cell-secreted macrophage migration inhibitory factor stimulates myeloid derived suppressor cell function and facilitates glioblastoma immune evasion. Stem Cells (Dayton, Ohio). PMID 27145382 DOI: 10.1002/stem.2393 |
0.444 |
|
| 2016 |
Wiechert A, Saygin C, Thiagarajan PS, Rao VS, Hale JS, Gupta N, Hitomi M, Nagaraj AB, DiFeo A, Lathia JD, Reizes O. Cisplatin induces stemness in ovarian cancer. Oncotarget. PMID 27105520 DOI: 10.18632/Oncotarget.8852 |
0.313 |
|
| 2016 |
Dermawan JK, Hitomi M, Silver DJ, Wu Q, Sandlesh P, Sloan AE, Purmal AA, Gurova KV, Rich JN, Lathia JD, Stark GR, Venere M. Pharmacological targeting of the histone chaperone complex FACT preferentially eliminates glioblastoma stem cells and prolongs survival in preclinical models. Cancer Research. PMID 26921329 DOI: 10.1158/0008-5472.Can-15-2162 |
0.385 |
|
| 2016 |
Silver DJ, Sinyuk M, Vogelbaum MA, Ahluwalia MS, Lathia JD. The intersection of cancer, cancer stem cells, and the immune system: therapeutic opportunities. Neuro-Oncology. 18: 153-9. PMID 26264894 DOI: 10.1093/neuonc/nov157 |
0.601 |
|
| 2015 |
Giachino C, Boulay JL, Ivanek R, Alvarado A, Tostado C, Lugert S, Tchorz J, Coban M, Mariani L, Bettler B, Lathia J, Frank S, Pfister S, Kool M, Taylor V. A Tumor Suppressor Function for Notch Signaling in Forebrain Tumor Subtypes. Cancer Cell. 28: 730-42. PMID 26669487 DOI: 10.1016/J.Ccell.2015.10.008 |
0.393 |
|
| 2015 |
Lathia JD, Mack SC, Mulkearns-Hubert EE, Valentim CL, Rich JN. Cancer stem cells in glioblastoma. Genes & Development. 29: 1203-17. PMID 26109046 DOI: 10.1101/gad.261982.115 |
0.381 |
|
| 2015 |
Hitomi M, Deleyrolle LP, Mulkearns-Hubert EE, Jarrar A, Li M, Sinyuk M, Otvos B, Brunet S, Flavahan WA, Hubert CG, Goan W, Hale JS, Alvarado AG, Zhang A, Rohaus M, ... ... Lathia JD, et al. Differential connexin function enhances self-renewal in glioblastoma. Cell Reports. 11: 1031-42. PMID 25959821 DOI: 10.1016/J.Celrep.2015.04.021 |
0.555 |
|
| 2014 |
Sundar SJ, Hsieh JK, Manjila S, Lathia JD, Sloan A. The role of cancer stem cells in glioblastoma. Neurosurgical Focus. 37: E6. PMID 25434391 DOI: 10.3171/2014.9.FOCUS14494 |
0.31 |
|
| 2014 |
Bai Y, Lathia JD, Zhang P, Flavahan W, Rich JN, Mattson MP. Molecular targeting of TRF2 suppresses the growth and tumorigenesis of glioblastoma stem cells. Glia. 62: 1687-98. PMID 24909307 DOI: 10.1002/Glia.22708 |
0.363 |
|
| 2014 |
Thorne AH, Meisen WH, Russell L, Yoo JY, Bolyard CM, Lathia JD, Rich J, Puduvalli VK, Mao H, Yu J, Caligiuri MA, Tridandapani S, Kaur B. Role of cysteine-rich 61 protein (CCN1) in macrophage-mediated oncolytic herpes simplex virus clearance. Molecular Therapy : the Journal of the American Society of Gene Therapy. 22: 1678-87. PMID 24895995 DOI: 10.1038/Mt.2014.101 |
0.326 |
|
| 2013 |
Hale JS, Sinyuk M, Rich JN, Lathia JD. Decoding the cancer stem cell hypothesis in glioblastoma. Cns Oncology. 2: 319-30. PMID 24379973 DOI: 10.2217/cns.13.23 |
0.331 |
|
| 2013 |
Zheng Q, Banaszak L, Fracci S, Basali D, Dunlap SM, Hursting SD, Rich JN, Hjlemeland AB, Vasanji A, Berger NA, Lathia JD, Reizes O. Leptin receptor maintains cancer stem-like properties in triple negative breast cancer cells. Endocrine-Related Cancer. 20: 797-808. PMID 24025407 DOI: 10.1530/Erc-13-0329 |
0.328 |
|
| 2013 |
Flavahan WA, Wu Q, Hitomi M, Rahim N, Kim Y, Sloan AE, Weil RJ, Nakano I, Sarkaria JN, Stringer BW, Day BW, Li M, Lathia JD, Rich JN, Hjelmeland AB. Brain tumor initiating cells adapt to restricted nutrition through preferential glucose uptake. Nature Neuroscience. 16: 1373-82. PMID 23995067 DOI: 10.1038/Nn.3510 |
0.323 |
|
| 2013 |
Schulte JD, Srikanth M, Das S, Zhang J, Lathia JD, Yin L, Rich JN, Olson EC, Kessler JA, Chenn A. Cadherin-11 regulates motility in normal cortical neural precursors and glioblastoma. Plos One. 8: e70962. PMID 23951053 DOI: 10.1371/Journal.Pone.0070962 |
0.373 |
|
| 2013 |
Liu WM, Huang P, Kar N, Burgett M, Muller-Greven G, Nowacki AS, Distelhorst CW, Lathia JD, Rich JN, Kappes JC, Gladson CL. Lyn facilitates glioblastoma cell survival under conditions of nutrient deprivation by promoting autophagy. Plos One. 8: e70804. PMID 23936469 DOI: 10.1371/Journal.Pone.0070804 |
0.352 |
|
| 2013 |
Cheng L, Huang Z, Zhou W, Wu Q, Donnola S, Liu JK, Fang X, Sloan AE, Mao Y, Lathia JD, Min W, McLendon RE, Rich JN, Bao S. Glioblastoma stem cells generate vascular pericytes to support vessel function and tumor growth. Cell. 153: 139-52. PMID 23540695 DOI: 10.1016/J.Cell.2013.02.021 |
0.363 |
|
| 2012 |
Lathia JD, Li M, Hall PE, Gallagher J, Hale JS, Wu Q, Venere M, Levy E, Rani MR, Huang P, Bae E, Selfridge J, Cheng L, Guvenc H, McLendon RE, et al. Laminin alpha 2 enables glioblastoma stem cell growth. Annals of Neurology. 72: 766-78. PMID 23280793 DOI: 10.1002/Ana.23674 |
0.419 |
|
| 2012 |
Hale JS, Li M, Sinyuk M, Jahnen-Dechent W, Lathia JD, Silverstein RL. Context dependent role of the CD36--thrombospondin--histidine-rich glycoprotein axis in tumor angiogenesis and growth. Plos One. 7: e40033. PMID 22808089 DOI: 10.1371/Journal.Pone.0040033 |
0.33 |
|
| 2012 |
Kim Y, Kim E, Wu Q, Guryanova O, Hitomi M, Lathia JD, Serwanski D, Sloan AE, Weil RJ, Lee J, Nishiyama A, Bao S, Hjelmeland AB, Rich JN. Platelet-derived growth factor receptors differentially inform intertumoral and intratumoral heterogeneity. Genes & Development. 26: 1247-62. PMID 22661233 DOI: 10.1101/Gad.193565.112 |
0.348 |
|
| 2012 |
Joo KM, Jin J, Kim E, Ho Kim K, Kim Y, Gu Kang B, Kang YJ, Lathia JD, Cheong KH, Song PH, Kim H, Seol HJ, Kong DS, Lee JI, Rich JN, et al. MET signaling regulates glioblastoma stem cells. Cancer Research. 72: 3828-38. PMID 22617325 DOI: 10.1158/0008-5472.Can-11-3760 |
0.366 |
|
| 2012 |
Huang P, Rani MR, Ahluwalia MS, Bae E, Prayson RA, Weil RJ, Nowacki AS, Hedayat H, Sloan AE, Lathia JD, Rich JN, Tipps R, Gladson CL. Endothelial expression of TNF receptor-1 generates a proapoptotic signal inhibited by integrin α6β1 in glioblastoma. Cancer Research. 72: 1428-37. PMID 22396498 DOI: 10.1158/0008-5472.Can-11-2621 |
0.54 |
|
| 2011 |
Hjelmeland AB, Lathia JD, Sathornsumetee S, Rich JN. Twisted tango: brain tumor neurovascular interactions. Nature Neuroscience. 14: 1375-81. PMID 22030548 DOI: 10.1038/Nn.2955 |
0.382 |
|
| 2011 |
Lathia JD, Gallagher J, Myers JT, Li M, Vasanji A, McLendon RE, Hjelmeland AB, Huang AY, Rich JN. Direct in vivo evidence for tumor propagation by glioblastoma cancer stem cells. Plos One. 6: e24807. PMID 21961046 DOI: 10.1371/Journal.Pone.0024807 |
0.396 |
|
| 2011 |
Eyler CE, Wu Q, Yan K, MacSwords JM, Chandler-Militello D, Misuraca KL, Lathia JD, Forrester MT, Lee J, Stamler JS, Goldman SA, Bredel M, McLendon RE, Sloan AE, Hjelmeland AB, et al. Glioma stem cell proliferation and tumor growth are promoted by nitric oxide synthase-2. Cell. 146: 53-66. PMID 21729780 DOI: 10.1016/J.Cell.2011.06.006 |
0.376 |
|
| 2011 |
Lathia JD, Venere M, Rao MS, Rich JN. Seeing is believing: are cancer stem cells the Loch Ness monster of tumor biology? Stem Cell Reviews. 7: 227-37. PMID 20957452 DOI: 10.1007/S12015-010-9194-6 |
0.385 |
|
| 2010 |
Cao Y, Lathia JD, Eyler CE, Wu Q, Li Z, Wang H, McLendon RE, Hjelmeland AB, Rich JN. Erythropoietin Receptor Signaling Through STAT3 Is Required For Glioma Stem Cell Maintenance. Genes & Cancer. 1: 50-61. PMID 20657792 DOI: 10.1177/1947601909356352 |
0.378 |
|
| 2010 |
Lathia JD, Gallagher J, Heddleston JM, Wang J, Eyler CE, Macswords J, Wu Q, Vasanji A, McLendon RE, Hjelmeland AB, Rich JN. Integrin alpha 6 regulates glioblastoma stem cells. Cell Stem Cell. 6: 421-32. PMID 20452317 DOI: 10.1016/J.Stem.2010.02.018 |
0.338 |
|
| 2010 |
Chigurupati S, Venkataraman R, Barrera D, Naganathan A, Madan M, Paul L, Pattisapu JV, Kyriazis GA, Sugaya K, Bushnev S, Lathia JD, Rich JN, Chan SL. Receptor channel TRPC6 is a key mediator of Notch-driven glioblastoma growth and invasiveness. Cancer Research. 70: 418-27. PMID 20028870 DOI: 10.1158/0008-5472.Can-09-2654 |
0.345 |
|
| 2010 |
Wang J, Wakeman TP, Lathia JD, Hjelmeland AB, Wang XF, White RR, Rich JN, Sullenger BA. Notch promotes radioresistance of glioma stem cells. Stem Cells (Dayton, Ohio). 28: 17-28. PMID 19921751 DOI: 10.1002/Stem.261 |
0.311 |
|
| 2009 |
Zhang P, Lathia JD, Flavahan WA, Rich JN, Mattson MP. Squelching glioblastoma stem cells by targeting REST for proteasomal degradation. Trends in Neurosciences. 32: 559-65. PMID 19748686 DOI: 10.1016/J.Tins.2009.07.005 |
0.356 |
|
| 2009 |
Schilling SH, Hjelmeland AB, Radiloff DR, Liu IM, Wakeman TP, Fielhauer JR, Foster EH, Lathia JD, Rich JN, Wang XF, Datto MB. NDRG4 is required for cell cycle progression and survival in glioblastoma cells. The Journal of Biological Chemistry. 284: 25160-9. PMID 19592488 DOI: 10.1074/Jbc.M109.012484 |
0.34 |
|
| 2009 |
Li Z, Bao S, Wu Q, Wang H, Eyler C, Sathornsumetee S, Shi Q, Cao Y, Lathia J, McLendon RE, Hjelmeland AB, Rich JN. Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells. Cancer Cell. 15: 501-13. PMID 19477429 DOI: 10.1016/J.Ccr.2009.03.018 |
0.395 |
|
| 2008 |
Wang J, Wang H, Li Z, Wu Q, Lathia JD, McLendon RE, Hjelmeland AB, Rich JN. c-Myc is required for maintenance of glioma cancer stem cells. Plos One. 3: e3769. PMID 19020659 DOI: 10.1371/Journal.Pone.0003769 |
0.324 |
|
| Show low-probability matches. |